Optimal Timing of Invasive Coronary Angiography following NSTEMI [PDF]
Journal of Interventional Cardiology, 2020 Objective. To obtain a real-world perspective of the optimal timing of angiography performed within 24 hours of admission with non-ST elevation myocardial infarction (NSTEMI). Background. Current guidelines recommend angiography within 24 hours of hospitalisation with NSTEMI.
Mahendiran, Thabo +13 more
openaire +6 more sources
Investigation into miRNA profile in patient groups with and without ST elevation
Türk Biyokimya Dergisi, 2023 Because acute myocardial infarction (AMI) may occur suddenly and cannot be predicted, it is critical to identify early diagnosis markers. In recent years, in addition to the developing diagnostic methods, other markers that may be related to the ...
Bobusoglu Onur +4 more
doaj +1 more source
Український журнал серцево-судинної хірургії, 2022 Coronary artery bypass grafting (CABG) has long been considered the gold standard in the treatment of patients with lesions of the left main (LM) coronary artery.
Sergii V. Salo +4 more
doaj +1 more source
TULBURĂRILE HEMOSTAZEI LA PACIENȚII CU NSTEMI ȘI MARKERII DE DIAGNOSTIC
Buletinul Academiei de Ştiinţe a Moldovei: Ştiinţe Medicale, 2022 Background. Hemostasis disorder is an important mechanism of cardiovascular disease, and its pathogenetic contribution to the evolution of NSTEMI is particularly notable in the context of the significance of the pathophysiological pattern caused by ...
DANILA Tatiana +4 more
doaj +1 more source
Glycoprotein IIb/IIIa Inhibitors Use and Outcome after Percutaneous Coronary Intervention for Non-ST Elevation Myocardial Infarction [PDF]
, 2014 Aims. We investigate the effect of glycoprotein IIb/IIIa (GP IIb/IIIa) inhibitors on long-term outcomes following percutaneous coronary intervention (PCI) after non-ST elevation myocardial infarction (NSTEMI). Meta-analyses indicate that these agents are
Antoniou, S +9 more
core +4 more sources
Access and non–access site bleeding after percutaneous coronary intervention and risk of subsequent mortality and major adverse cardiovascular events:Systematic review and meta-analysis [PDF]
, 2015 Background: The prognostic impact of site-specific major bleeding complications after percutaneous coronary intervention (PCI) has yielded conflicting data.
Buchan, Iain +10 more
core +1 more source
Managing NSTEMI in older patients [PDF]
The Lancet, 2021 Versaci, Francesco +2 more
openaire +4 more sources
Multiple Myeloma Presenting with Nstemi [PDF]
Indian Journal of Cardiovascular Disease in Women WINCARS, 2016 AbstractMultiple myeloma, also known as plasma cell myeloma, is a cancer of plasma cells, a type of white blood cell normally responsible for producing antibodies. Multiple myeloma is associated with hyperviscosity of the blood depending on the properties of the para-protein.
M. kiran, A. Praveen
openaire +1 more source
Pakistan Armed Forces Medical Journal, 2020 Objective: To determine the efficacy of intracoronary verapamil vs adenosine in restoration of coronary blood flow, post PCI in patients with No-Reflow. Study Design: Double blind (patient/operator blind) randomized control trial.
Mohsin Saif +8 more
doaj +1 more source
Examining adherence to activity monitoring devices to improve physical activity in adults with cardiovascular disease: A systematic review [PDF]
, 2019 Background Activity monitoring devices are currently being used to facilitate and monitor physical activity. No prior review has examined adherence to the use of activity monitoring devices amongst adults with cardiovascular disease.
Beks, Hannah +12 more
core +1 more source